Feedback / Questions
brontictuzumab (OMP-52M51) - Mereo Biopharma
OncoMed: J.P.Morgan Healthcare Conference
(OncoMed)
-
Jan 30, 2016 -
Anticipated data from P1 trial (NCT01703572) in hematological malignancies in H2 2016
Anticipated P1 data
•
Hematological Malignancies • Oncology
http://investor.shareholder.com/oncomed/events.cfm
Jan 30, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.